Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
44.90
+2.29 (5.37%)
At close: Dec 5, 2025, 4:00 PM EST
45.00
+0.10 (0.22%)
After-hours: Dec 5, 2025, 7:55 PM EST

Vera Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Vera Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $63.13, which forecasts a 40.60% increase in the stock price over the next year. The lowest target is $26 and the highest is $100.

Price Target: $63.13 (+40.60%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$26$63.13$61$100
Change-42.09%+40.60%+35.86%+122.72%

Analyst Ratings

The average analyst rating for Vera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy222334
Buy544443
Hold122222
Sell000000
Strong Sell000000
Total888999

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Strong Buy
Maintains
$60$73
Strong BuyMaintains$60$73+62.58%Dec 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$85$90
Strong BuyMaintains$85$90+100.45%Nov 10, 2025
JP Morgan
JP Morgan
Buy
Maintains
$53$52
BuyMaintains$53$52+15.81%Nov 7, 2025
B of A Securities
B of A Securities
Strong Buy
Initiates
$48
Strong BuyInitiates$48+6.90%Oct 16, 2025
JP Morgan
JP Morgan
Buy
Maintains
$56$53
BuyMaintains$56$53+18.04%Aug 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
35.19M
EPS This Year
-4.69
from -2.75
EPS Next Year
-4.87
from -4.69
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------35.19M
Revenue Growth
-------
EPS
-166.93-2.43-3.35-2.25-2.75-4.69-4.87
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1514
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
Highn/a66.7M
Avgn/a35.2M
Lown/a2.5M

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-4.60-3.34
Avg-4.69-4.87
Low-5.17-6.29

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.